Document text
For more information: www.cdc.gov/COVID19
COVID -19 Vaccine Program Updates
Georgina Peacock, MD, MPH, FAAP
Director, Immunization Services Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention (CDC)
Overarching Objectives for the U.S. COVID -19
Vaccination Program
Ensure safety and
effectiveness of
COVID -19
vaccinesReduce mortality,
morbidity, and
incidence of
COVID -19 diseaseHelp minimize
disruption to
society and
economy, including
maintaining
healthcare capacityEnsure equity in
vaccine allocation
and distribution
End of the Public Health Emergency on May 11, 2023
and the COVID -19 Vaccination Program
▪What will change
▪Possible reduced submission of vaccine administration data from some
jurisdictions which may limit completeness of administration data on a national
level
▪Most jurisdictions have signed a COVID -19 vaccine Data Use Agreement extension
through the end of 2023
End of the Public Health Emergency on May 11, 2023
and the COVID -19 Vaccination Program
•What will notchange
▪CDC working with public and private partners to learn more about the short -and
long -term health effects associated with COVID -19, who is affected, and why –
and implementing vaccine recommendations to optimize protection
▪FDA’s EUAs for COVID -19 products (including vaccines)
▪All vaccines purchased by the U.S. government will continue to be distributed and
available for free
Public Health Emergency ending ≠ Commercialization
Commercialization of COVID -19 Vaccines
•Commercialization of COVID -19 vaccines is the transition of vaccines previously purchased by the U.S. Government
(USG), to established pathways of procurement, distribution, and payment by both public and private payers
•Timeline: Likely in early Fall
–Considerations include what will be authorized by FDA and recommended by CDC, and what will align with a
strain change for potential variants
•After commercialization, vaccines will remain free for most people through the Vaccines for Children Program,
Children’s Health Insurance Program, most commercial insurance, Medicare, and Medicaid programs
https://aspr.hhs.gov/COVID -19/Pages/FAQ -Commercialization.aspx
▪Vaccination equity : when everyone has fair and just access to
vaccination.
▪CDC works with national, state, tribal, territorial, healthcare, and
community partners to ensure all people have fair and just
access to vaccination.
▪CDC uses a Social Vulnerability Index to support areas at
increased risk.
▪Making sure the uninsured have continued access to COVID -19
vaccines with as few financial barriers as possible is a top
priorityFocus on Vaccination Equity
Pharmacies Help
Increase Access
to Vaccines
▪HHS recently announced intent to amend the declaration under the PREP Act for
medical countermeasures against COVID -19.
▪By issuing this amendment, the HHS Secretary intends to extend immunity liability to
pharmacists, pharmacy interns, and pharmacy technicians to administer COVID -19
and seasonal influenza vaccines through December 2024.
▪Additional information on the planned amendment to the declaration under the
PREP Act can be found at https://www.hhs.gov/about/news/2023/04/14/factsheet -
hhs-announces -amend -declaration -prep -act-medical -countermeasures -against -
covid19.htmlPublic Readiness and Emergency Preparedness (PREP)
Act for Medical Countermeasures against COVID -19
Inflation Reduction Act
https://www.cms.gov/newsroom/fact -sheets/inflation -reduction -act-lowers -health -care -costs -millions -americans
The proposed Vaccines for Adults program would reduce the spread of vaccine -
preventable diseases and pave the way to greater health equity
VACCINES FOR
ADULTS
PROGRAM
VACCINE PURCHASE
Purchase of recommended
vaccines for all uninsured
adults
PROGRAM OPERATIONS
CDC staff and systems for scientific
and policy support, program
monitoring, and vaccine safety and
distributionPROVIDER FEES
Covering the cost of supplies,
patient education, storage, and
staffing
PROVIDER FEE
MANAGEMENT
Contracts to administer the provider
reimbursement process
VACCINE CONFIDENCE
Support vaccine equity through partnerships, communications, and
technical assistanceAND EQUITY ACTIVITIES**These activities are funded
in the FY24 CDC Budget with
base immunization funding,
not the newly proposed
mandatory funding proposal
that would support the rest
of these activities.
FY24 President's Budget Request: Vaccines for Adults (VFA)
Looking Forward
Continued
surveillance of
virusesContinuing focus
on vaccine equity
Continued vaccine
effectiveness
studies
Communicating about
the Public Health
Emergency ending
Collaborating with
partners on vaccine
commercialization
Increasing
vaccine
confidence